An AI drug discovery company building digital patient models and autonomous research agents to find targets and design small-molecule therapeutics.
Omic Inc.
Released August 14, 2026
Drug-target affinity model scoring small molecules across the whole human proteome to yield tissue-weighted off-target binding profiles.